Vanita Noronha, Atul Budukh, Pankaj Chaturvedi, Anne Srikanth et al.
rearrangements are noted in 5-7%. Therapies are similar to global standards, although access to newer modalities and molecules is a challenge. Collaborative research, political will with various policy changes and patient advocacy are urgently needed.
Vanita Noronha, Vandana Mahajan, Ravi Prakash, Sanjeev Sharma et al.
Globally, patient advocacy and support groups have helped advance science and patient care, however, this is an unmet need in India. In 2017, Rise To Survive, a support group for patients with ALK-positive lung cancer, was created in India.1https://risetosurvivecancer.com/2018/09/05/alk-positive-ind...